4-Methoxy-6-methyl-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline
| Title | Journal |
|---|---|
| [Retrospective study on intravenous compound injection of cancer pain patients with oxycodone and hydrocotarnine preparation in comparison with subcutaneous administration]. | Gan to kagaku ryoho. Cancer & chemotherapy 20120501 |
| [Solutions for the clinical problems of analgesics for cancer pain treatment in Japan]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110101 |
| [Efficacy and safety of compound oxycodone injection for cancer pain relief-a multicenter survey of prescriptions]. | Gan to kagaku ryoho. Cancer & chemotherapy 20100501 |
| [Efficacy and safety of continuous subcutaneous injection of the compound oxycodone in cancer pain management: the first 4-year audit]. | Gan to kagaku ryoho. Cancer & chemotherapy 20091001 |
| Effect of hydrocotarnine on cytochrome P450 and P-glycoprotein. | Drug metabolism and pharmacokinetics 20090101 |
| [Conversion ratio between intravenous oxycodone/hydrocotarnine and sustained-release oral oxycodone in patients with cancer pain]. | Gan to kagaku ryoho. Cancer & chemotherapy 20071201 |
| Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain. | Biological & pharmaceutical bulletin 20071101 |
| Comparison of the various opiate alkaloid contaminants and their metabolites found in illicit heroin with 6-monoacetyl morphine as indicators of heroin ingestion. | Journal of analytical toxicology 20060501 |
| Determination of oxycodone and hydrocotarnine in cancer patient serum by high-performance liquid chromatography with electrochemical detection. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20050301 |